Midgard Science

Vernalis

Cambridge, United Kingdom vernalis.com

From their website, Nov 2026

Work here? Claim this listing

About

Vernalis is a drug discovery CRO that works with biotech, pharma and other collaborators on early discovery programs from hit identification to candidate selection. It provides integrated services in protein sciences, screening, structural biology, chemistry, biophysics, cell biology, ADME/DMPK, informatics and in vivo pharmacology from its site in Cambridge, United Kingdom.

Services

  • Protein Sciences

    Produces and characterises proteins for drug discovery, including construct design, expression and purification across multiple systems.

    Protein production

  • Hit Identification Services

    Finds starting points for targets using biochemical assays, DEL, ASMS, in silico screening and fragment-based drug discovery.

    Assays & in vitro testing

  • Hit ID Platform

    Provides end-to-end hit identification across multiple screening platforms.

    Assays & in vitro testing

  • Chemistry / Hit to Lead Services

    Designs, synthesises and optimises compounds from fragment hits to lead series and beyond.

  • Structural Biology Services

    Determines protein and ligand-protein structures using X-ray crystallography and NMR to guide drug design.

    Assays & in vitro testing

  • Biophysical Screening Services

    Validates and characterises hits using NMR, SPR, ITC, MST, TSA and ASMS.

    Assays & in vitro testing

  • Drug Discovery Informatics

    Applies cheminformatics, data science and software engineering to support data-driven discovery decisions.

  • Cell Biology Services

    Runs cell-based assays to assess target engagement, compound activity and mechanism of action.

    Assays & in vitro testing

  • ADME DMPK Services

    Provides in vitro ADME profiling, metabolite identification and ex vivo bioanalysis to support candidate selection.

    ADME, DMPK & toxicology

  • In Vivo Pharmacology Services

    Supports outsourced in vivo study design, management, bioanalysis and PK/PD analysis through external CRO partners.

    ADME, DMPK & toxicology

  • DEL Technology

    Screens DNA-encoded libraries against protein targets to identify hits for challenging targets.

    Assays & in vitro testing

  • PAC-FragmentDEL

    Uses photoactivated covalent capture with DNA-encoding for fragment screening with small protein requirements.

    Assays & in vitro testing

  • Fragment-Based Drug Discovery

    Screens low-molecular-weight fragments and grows them into lead series using integrated screening, structural and chemistry expertise.

    Assays & in vitro testing

  • Protein Science

    Expresses, purifies, and engineers proteins for biophysical and structural studies.

    Protein production

  • Hit ID and Assay

    Finds and validates hits using biochemical assays, DEL, in silico screening, fragment-based drug discovery, and assay development.

    Assays & in vitro testing

  • Biophysics and Structural Biology

    Uses NMR, mass spectrometry, SPR, ITC, and X-ray crystallography to validate and progress chemical series.

    Assays & in vitro testing

  • Chemistry and Computational

    Supports medicinal chemistry, synthetic chemistry, flow chemistry, analytical chemistry, and computational chemistry for lead optimization and candidate selection.

  • Cell biology

    Characterizes and supports chemical series through cell biology studies.

    Assays & in vitro testing

  • DMPK

    Supports chemical series through lead optimization and pre-clinical studies with DMPK work.

    ADME, DMPK & toxicology

What to send
Minimal protein requirement for PAC-FragmentDEL · Small amounts of target protein for PAC-FragmentDEL

Capabilities

As they state on their website or in their listing.

Processes
Small molecule · Peptide · NMR · SPR · Biochemical assays · Mammalian expression · Insect cells
Capacity
Screening billions of compounds in one experiment · Over 8,000 crystal structures determined for more than 70 targets · Multiple expression systems: E. coli, yeast, insect and mammalian cell · Milligram-to-kilogram capabilities · Bioreactor for precise control of growth conditions and optimal yield · 50k lead-like chemical space screening library
Data supplied
NMR

Equipment

  • Biacore T200
  • Biacore 1S+
  • Biacore 8K
  • Bruker D8 venture
  • LC-MS/MS
  • LCMS-MS
  • NMR
  • SPR
  • ITC
  • MST
  • TSA
  • ASMS
  • X-ray crystallography
  • Next Generation Sequencing
  • ÄKTA Pure
  • ÄKTA Avant
  • Agilent QTOF
  • Syrris Asia flow chemistry systems

Materials

  • Yeast
  • Insect cells

Industries served

  • Biotech
  • Pharma

Company

Type
CRO
Founded
2001
Size
51-200 employees

Locations

Address
01 Find Us Granta Park is just 8 miles from Cambridge city centre, 20 minutes from London St
Sites
Cambridge, United Kingdom

Public records

Wikidata
Q7921942 source

Similar labs

Work here? Claim this listing